This company has been acquired
Hanger (HNGR) Stock Overview
Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
HNGR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Hanger, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$18.72 |
| 52 Week High | US$22.67 |
| 52 Week Low | US$13.42 |
| Beta | 1.36 |
| 1 Month Change | 0.32% |
| 3 Month Change | 27.35% |
| 1 Year Change | -14.17% |
| 3 Year Change | -4.00% |
| 5 Year Change | 70.18% |
| Change since IPO | 284.00% |
Recent News & Updates
Hanger stock jumps postmarket on deal to be taken private at $1.25B enterprise value
Hanger (NYSE:HNGR) stock jumped ~24% postmarket on Thursday after the firm said it will be acquired by healthcare investment firm Patient Square Capital at a total enterprise value of ~$1.25B. HNGR stockholders will receive $18.75/share in cash, representing ~29% premium to the 30-day volume weighted average price ending Jul. 20. On closing of the deal, HNGR will become a privately held company, and its stock will be delisted from NYSE. The deal will be financed through a combination of committed equity financing from Patient Square Equity Partners and committed debt financing to be led by funds managed by Ares Capital Management. The deal is expected to close in Q4. HNGR will continue to be led by CEO Vinit Asar and will maintain its headquarters in Austin, Texas. HNGR will no longer host an earnings conference call for Q2 results and expects to issue its results for the quarter ended Jun. 30 on or about Aug. 8.Is It Too Late To Consider Buying Hanger, Inc. (NYSE:HNGR)?
Hanger, Inc. ( NYSE:HNGR ), might not be a large cap stock, but it received a lot of attention from a substantial price...Recent updates
Shareholder Returns
| HNGR | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | -1.0% |
| 1Y | -14.2% | 38.5% | 14.7% |
Return vs Industry: HNGR underperformed the US Healthcare industry which returned 7.7% over the past year.
Return vs Market: HNGR exceeded the US Market which returned -23.2% over the past year.
Price Volatility
| HNGR volatility | |
|---|---|
| HNGR Average Weekly Movement | 7.4% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: HNGR has not had significant price volatility in the past 3 months.
Volatility Over Time: HNGR's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1861 | 5,200 | Vinit Asar | hangerclinic.com |
Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers.
Hanger, Inc. Fundamentals Summary
| HNGR fundamental statistics | |
|---|---|
| Market cap | US$732.39m |
| Earnings (TTM) | US$37.29m |
| Revenue (TTM) | US$1.18b |
Is HNGR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HNGR income statement (TTM) | |
|---|---|
| Revenue | US$1.18b |
| Cost of Revenue | US$796.67m |
| Gross Profit | US$378.85m |
| Other Expenses | US$341.55m |
| Earnings | US$37.29m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.95 |
| Gross Margin | 32.23% |
| Net Profit Margin | 3.17% |
| Debt/Equity Ratio | 381.4% |
How did HNGR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/03 19:51 |
| End of Day Share Price | 2022/09/30 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hanger, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adam Feinstein | Barclays |
| Robert Labick | CJS Securities, Inc. |
| Lawrence Solow | CJS Securities, Inc. |